Skip to main content
Article
Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II Study.
The Online journal of current clinical trials (1992)
  • M. Sznol, National Institutes of Health
  • R. G. Steis, National Institutes of Health
  • J. W. Smith, National Institutes of Health
  • J. E. Janik, National Institutes of Health
  • W. H. Sharfman, National Institutes of Health
  • W. J. Urba, National Institutes of Health
  • R. G. Fenton, National Institutes of Health
  • S. P. Creekmore, National Institutes of Health
  • J. Beveridge, National Institutes of Health
  • D. L. Longo, National Institutes of Health
Publication Date
July 1, 1992
Citation Information
M. Sznol, R. G. Steis, J. W. Smith, J. E. Janik, et al.. "Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II Study." The Online journal of current clinical trials Vol. Doc No 9 (1992)
Available at: http://works.bepress.com/walter-urba/44/